KAINOS Laboratories (TSE:4556) Cash Flow for Dividends: 円-156 Mil (TTM As of Mar. 2026)


TSE:4556 KAINOS Laboratories Inc TSE:4556
39 GF Score
Price 円2,268.00
GF Value 円1,281.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is KAINOS Laboratories Cash Flow for Dividends?

KAINOS Laboratories TSE:4556 39 Cash Flow for Dividends is 円-156 Mil as of Mar. 2026. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

KAINOS Laboratories's cash flow for dividends for the six months ended in Mar. 2026 was 円-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was 円-156 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

KAINOS Laboratories's quarterly payment of dividends increased from Mar. 2025 (円-0 Mil) to Sep. 2025 (円-156 Mil) but then declined from Sep. 2025 (円-156 Mil) to Mar. 2026 (円-0 Mil).

KAINOS Laboratories's annual payment of dividends increased from Mar. 2024 (円-111 Mil) to Mar. 2025 (円-142 Mil) and increased from Mar. 2025 (円-142 Mil) to Mar. 2026 (円-156 Mil).

KAINOS Laboratories Cash Flow for Dividends Related Terms

KAINOS Laboratories Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for KAINOS Laboratories's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KAINOS Laboratories Cash Flow for Dividends Chart

KAINOS Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65.68 -111.74 -111.17 -142.20 -155.88

KAINOS Laboratories Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -142.08 -0.12 -155.57 -0.31
TSE:4556
39GF Score
KAINOS Laboratories Inc TSE:4556
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KAINOS Laboratories Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-156 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of 円-156 Mil mean?
KAINOS Laboratories (TSE:4556) has a Cash Flow for Dividends of 円-156 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for KAINOS Laboratories and its competitors.
Is KAINOS Laboratories' Cash Flow for Dividends too high?
KAINOS Laboratories' current Cash Flow for Dividends is 円-156 Mil. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Cash Flow for Dividends compare to ISRG and BDX?
KAINOS Laboratories' Cash Flow for Dividends of 円-156 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for KAINOS Laboratories and its competitors. KAINOS Laboratories's current Cash Flow for Dividends is 円-156 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current Cash Flow for Dividends is 円-156 Mil. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Cash Flow for Dividends is 円-156 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?

Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued. The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99. GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.

Key valuation signals for TSE:4556:

  • Cash Flow for Dividends: 円-156 Mil
  • GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KAINOS Laboratories Business Description

Address 38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score

Get the complete analysis for TSE:4556

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,268.00
Price
円1,281.99
GF Value